Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.

Hoxha A, Favaro M, Calligaro A, Del Ross T, Ruffatti AT, Infantolino C, Tonello M, Mattia E, Ruffatti A.

Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697665. [Epub ahead of print]

PMID:
31634958
2.

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Hoxha A, Tincani A, Nalli C, Marozio L, Maina A, Espinosa G, Ríos-Garcés R, Cervera R, Carolis S, Monteleone G, Latino O, Udry S, LLurba E, Garrido-Gimenez C, Trespidi L, Gerosa M, Chighizola CB, Rovere-Querini P, Canti V, Mayer-Pickel K, Tabacco S, Arnau A, Trapé J, Ruiz-Hidalgo D, Sos L, Farran-Codina I.

Rheumatology (Oxford). 2019 Oct 3. pii: kez419. doi: 10.1093/rheumatology/kez419. [Epub ahead of print]

PMID:
31580459
3.

Therapeutic apheresis during pregnancy: A single center experience.

Colpo A, Marson P, Pavanello F, Tison T, Gervasi MT, Zambon A, Ruffatti A, De Silvestro G, Hoxha A.

Transfus Apher Sci. 2019 Sep 5. pii: S1473-0502(19)30185-5. doi: 10.1016/j.transci.2019.07.009. [Epub ahead of print]

PMID:
31522920
4.

Layered Double Hydroxide Fluoride Release in Dental Applications: A Systematic Review.

Hoxha A, Gillam DG, Bushby AJ, Agha A, Patel MP.

Dent J (Basel). 2019 Sep 2;7(3). pii: E87. doi: 10.3390/dj7030087. Review.

5.

An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.

Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A.

Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005. eCollection 2019.

6.

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.

Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.

Thromb Res. 2019 May;177:157-160. doi: 10.1016/j.thromres.2019.03.006. Epub 2019 Mar 8.

PMID:
30903876
7.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

8.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group.

Autoimmun Rev. 2019 Apr;18(4):406-414. doi: 10.1016/j.autrev.2018.12.006. Epub 2019 Feb 15.

PMID:
30772493
9.

The Role of Premotor Areas in Dual Tasking in Healthy Controls and Persons With Multiple Sclerosis: An fNIRS Imaging Study.

Saleh S, Sandroff BM, Vitiello T, Owoeye O, Hoxha A, Hake P, Goverover Y, Wylie G, Yue G, DeLuca J.

Front Behav Neurosci. 2018 Dec 11;12:296. doi: 10.3389/fnbeh.2018.00296. eCollection 2018.

10.

Impact of Clopidogrel Loading for Coronarography on Bleeding After Urgent First Time CABG.

Hoxha A, Shehu S, Deveja R, Qirjazi T.

Med Arch. 2018 Nov;72(5):319-324. doi: 10.5455/medarh.2018.72.319-324.

11.

Supra-Spinal Modulation Of Walking In Healthy Individuals And Persons With Multiple Sclerosis: A fNIRS Mobile Imaging Study.

Saleh S, Sandroff BM, Owoeye O, Vitiello T, Hoxha A, Yue G, DeLuca J.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:3156-3159. doi: 10.1109/EMBC.2018.8513052.

PMID:
30441064
12.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group.

Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.

13.

Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.

Ruffatti A, De Silvestro G, Marson P, Tonello M, Calligaro A, Favaro M, Del Ross T, Hoxha A, Mattia E, Pengo V.

J Autoimmun. 2018 Sep;93:124-130. doi: 10.1016/j.jaut.2018.07.001. Epub 2018 Jul 7.

PMID:
30146007
14.

Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.

Canti V, Del Rosso S, Tonello M, Lucianò R, Hoxha A, Coletto LA, Vaglio Tessitore I, Rosa S, Manfredi AA, Castiglioni MT, Ruffatti A, Rovere-Querini P.

J Rheumatol. 2018 Aug;45(9):1263-1272. doi: 10.3899/jrheum.170751. Epub 2018 Jul 15.

PMID:
30008452
15.

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A.

Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12.

PMID:
30002145
16.

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.

Tonello M, Mattia E, Del Ross T, Favaro M, Calligaro A, Hoxha A, Bison E, Pengo V, Ruffatti A.

Clin Chim Acta. 2018 Oct;485:74-78. doi: 10.1016/j.cca.2018.06.037. Epub 2018 Jun 25.

PMID:
29953850
17.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

18.

European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block.

Kyriakidis NC, Kockum I, Julkunen H, Hoxha A, Salomonsson S, Meneghel L, Ebbing C; Swedish Congenital Heart Block Study Group, Dilthey A, Eronen M, De Carolis S, Kiserud T, Ruffatti A, Kere J, Meisgen S, Wahren-Herlenius M.

Ann Rheum Dis. 2018 Sep;77(9):1381-1382. doi: 10.1136/annrheumdis-2018-212953. Epub 2018 Feb 16. No abstract available.

PMID:
29453219
19.

Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study.

Campello E, Radu CM, Tonello M, Kuzenko A, Bulato C, Hoxha A, Mattia E, Spiezia L, Ruffatti A, Simioni P.

Scand J Rheumatol. 2018 Nov;47(6):501-504. doi: 10.1080/03009742.2017.1372518. Epub 2018 Jan 8. No abstract available.

PMID:
29308695
20.

Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays.

Mattia E, Hoxha A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ghirardello A, Ruffatti A.

Clin Chem Lab Med. 2018 May 24;56(6):927-932. doi: 10.1515/cclm-2017-0704.

PMID:
29303768
21.

Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.

Taraborelli M, Reggia R, Dall'Ara F, Fredi M, Andreoli L, Gerosa M, Hoxha A, Massaro L, Tonello M, Costedoat-Chalumeau N, Cacoub P, Franceschini F, Meroni PL, Piette JC, Ruffatti A, Valesini G, Harris EN, Tincani A.

J Rheumatol. 2017 Aug;44(8):1165-1172. doi: 10.3899/jrheum.161364. Epub 2017 Jun 1.

PMID:
28572466
22.

Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Tonello M, Hoxha A, Mattia E, Zambon A, Visentin S, Cerutti A, Ghirardello A, Milanesi O, Ruffatti A.

Clin Rheumatol. 2017 May;36(5):1155-1160. doi: 10.1007/s10067-017-3572-2. Epub 2017 Feb 15.

PMID:
28204891
23.

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.

Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P; PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group.

Am J Obstet Gynecol. 2017 May;216(5):525.e1-525.e12. doi: 10.1016/j.ajog.2017.01.026. Epub 2017 Jan 30.

PMID:
28153662
24.

Detection of lupus anticoagulant in the era of direct oral anticoagulants.

Hoxha A, Banzato A, Ruffatti A, Pengo V.

Autoimmun Rev. 2017 Feb;16(2):173-178. doi: 10.1016/j.autrev.2016.12.010. Epub 2016 Dec 15. Review.

PMID:
27988438
25.
26.

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.

Hoxha A, Mattia E, Tonello M, Grava C, Pengo V, Ruffatti A.

Clin Chem Lab Med. 2017 May 1;55(6):890-898. doi: 10.1515/cclm-2016-0638.

PMID:
27816952
27.

Provider Perspectives on Safety in Primary Care in Albania.

Gabrani JC, Knibb W, Petrela E, Hoxha A, Gabrani A.

J Nurs Scholarsh. 2016 Nov;48(6):552-560. doi: 10.1111/jnu.12236. Epub 2016 Oct 25.

PMID:
27779820
28.

APS - Diagnostics and challenges for the future.

Pengo V, Bison E, Zoppellaro G, Padayattil Jose S, Denas G, Hoxha A, Ruffatti A, Banzato A.

Autoimmun Rev. 2016 Nov;15(11):1031-1033. doi: 10.1016/j.autrev.2016.07.028. Epub 2016 Jul 31. Review.

PMID:
27486689
29.

Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Hoxha A, Ruffatti A, Ambrosi A, Ottosson V, Hedlund M, Ottosson L, Anandapadamanaban M, Sunnerhagen M, Sonesson SE, Wahren-Herlenius M.

Clin Exp Immunol. 2016 Dec;186(3):284-291. doi: 10.1111/cei.12854. Epub 2016 Sep 13.

30.

Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.

Ruffatti A, Cerutti A, Favaro M, Del Ross T, Calligaro A, Hoxha A, Marson P, Leoni L, Milanesi O.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):706-13. Epub 2016 Jun 22.

PMID:
27385463
31.

Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study.

Hoxha A, Calligaro A, Di Poi E, Peccatori S, Favaro M, Del Ross T, Ramonda R, Grava C, Raffeiner B, Ravagni P, De Vita S, Ruffatti A.

Joint Bone Spine. 2017 Mar;84(2):169-173. doi: 10.1016/j.jbspin.2016.03.014. Epub 2016 Jun 22.

PMID:
27344079
32.

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U, Banzato A, Pengo V.

Clin Rev Allergy Immunol. 2017 Aug;53(1):28-39. doi: 10.1007/s12016-016-8571-6. Review.

PMID:
27342460
33.

Laboratory testing for antiphospholipid syndrome.

Pengo V, Banzato A, Bison E, Denas G, Zoppellaro G, Bracco A, Padayattil Jose S, Hoxha A, Ruffatti A.

Int J Lab Hematol. 2016 May;38 Suppl 1:27-31. doi: 10.1111/ijlh.12507. Epub 2016 May 9. Review.

PMID:
27161602
34.

Enhancement of Aedes albopictus collections by ovitrap and sticky adult trap.

Velo E, Kadriaj P, Mersini K, Shukullari A, Manxhari B, Simaku A, Hoxha A, Caputo B, Bolzoni L, Rosà R, Bino S, Reiter P, della Torre A.

Parasit Vectors. 2016 Apr 21;9:223. doi: 10.1186/s13071-016-1501-x.

35.

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study.

Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Del Ross T, Calligaro A, Tonello M, Nardelli GB.

J Reprod Immunol. 2016 Jun;115:14-9. doi: 10.1016/j.jri.2016.03.004. Epub 2016 Mar 29.

PMID:
27088752
36.

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.

Tonello M, Ruffatti A, Favaro M, Tison T, Del Ross T, Calligaro A, Hoxha A, Mattia E, Punzi L.

Lupus Sci Med. 2016 Mar 24;3(1):e000129. doi: 10.1136/lupus-2015-000129. eCollection 2016.

37.

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study.

Hoxha A, Calligaro A, Tonello M, Ramonda R, Carletto A, Paolazzi G, Bortolotti R, Del Ross T, Grava C, Boaretto M, Favaro M, Teghil V, Ruffatti A, Punzi L.

Joint Bone Spine. 2016 Mar;83(2):167-71. doi: 10.1016/j.jbspin.2015.04.020. Epub 2015 Dec 29.

PMID:
26750762
38.

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block.

Ruffatti A, Favaro M, Brucato A, Ramoni V, Facchinetti M, Tonello M, Del Ross T, Calligaro A, Hoxha A, Grava C, De Silvestro G.

Transfus Apher Sci. 2015 Dec;53(3):269-78. doi: 10.1016/j.transci.2015.11.006. Epub 2015 Nov 25. Review.

PMID:
26626966
39.

Diagnosis and therapy of antiphospholipid syndrome. Author's reply.

Pengo V, Hoxha A, Ruffatti A.

Pol Arch Med Wewn. 2015;125(10):785-6. No abstract available.

40.

The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints.

Galozzi P, Oliviero F, Frallonardo P, Favero M, Hoxha A, Scanu A, Lorenzin M, Ortolan A, Punzi L, Ramonda R.

Rheumatol Int. 2016 Mar;36(3):443-6. doi: 10.1007/s00296-015-3376-0. Epub 2015 Oct 6.

PMID:
26440935
41.

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.

Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calligaro A, Favaro M, Facchinetti M, Hoxha A, Punzi L.

Thromb Res. 2015 Nov;136(5):883-6. doi: 10.1016/j.thromres.2015.08.019. Epub 2015 Sep 5.

PMID:
26410418
42.

Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.

Hoxha A, Kärki T, Giambi C, Montano C, Sisto A, Bella A, D'Ancona F; Study Working Group.

J Hosp Infect. 2016 Jan;92(1):61-6. doi: 10.1016/j.jhin.2015.06.018. Epub 2015 Jul 29.

PMID:
26319590
43.

Diagnosis and therapy of antiphospholipid syndrome.

Pengo V, Denas G, Padayattil SJ, Zoppellaro G, Bison E, Banzato A, Hoxha A, Ruffatti A.

Pol Arch Med Wewn. 2015;125(9):672-7. Epub 2015 Aug 26. Review.

44.

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles.

Pengo V, Ruffatti A, Tonello M, Hoxha A, Bison E, Denas G, Padayattil Jose S, Zoppellaro G, Bracco A, Banzato A.

Thromb Res. 2015 Jul;136(1):161-3. doi: 10.1016/j.thromres.2015.04.031. Epub 2015 May 1.

PMID:
25959581
45.

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.

Meneghel L, Ruffatti A, Gavasso S, Tonello M, Mattia E, Spiezia L, Tormene D, Hoxha A, Fedrigo M, Simioni P.

Clin Chim Acta. 2015 Jun 15;446:201-5. doi: 10.1016/j.cca.2015.04.033. Epub 2015 Apr 30.

PMID:
25935129
46.

A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay.

Mattia E, Ruffatti A, Meneghel L, Tonello M, Faggian D, Hoxha A, Fedrigo M, Punzi L, Plebani M.

Clin Chim Acta. 2015 Jun 15;446:93-6. doi: 10.1016/j.cca.2015.04.012. Epub 2015 Apr 17.

PMID:
25892672
47.

Application of the Safety Attitudes Questionnaire (SAQ) in Albanian hospitals: a cross-sectional study.

Gabrani A, Hoxha A, Simaku A, Gabrani JC.

BMJ Open. 2015 Apr 15;5(4):e006528. doi: 10.1136/bmjopen-2014-006528.

48.

Erosive osteoarthritis, psoriatic arthritis and pseudogout; a casual association?

Hoxha A, Ruffatti A, Alberioli E, Lorenzin M, Oliviero F, Mattia E, Punzi L, Ramonda R.

Clin Rheumatol. 2016 Jul;35(7):1885-9. doi: 10.1007/s10067-015-2927-9. Epub 2015 Apr 2.

PMID:
25833145
49.

Are biological drugs safe in pregnancy?

Calligaro A, Hoxha A, Ruffatti A, Punzi L.

Reumatismo. 2015 Mar 31;66(4):304-17. doi: 10.4081/reumatismo.2014.798. Review.

50.

Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.

Tonello M, Ruffatti A, Marson P, Tison T, Marozio L, Hoxha A, De Silvestro G, Punzi L.

Transfusion. 2015 Jul;55(7):1782-6. doi: 10.1111/trf.13046. Epub 2015 Mar 30.

PMID:
25825254

Supplemental Content

Support Center